Key Metrics
6.1
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.001 - 0.005
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
39
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.87
5-Year SI
5-year SI
- N/A 2-year SI
- 0.86 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Infectious Diseases
SJR
- Q1 Infectious Diseases
- Q1 Microbiology (medical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.81
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
51%
4 to 6 months
43%
7 to 9 months
5%
Above 9 months
1%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Pneumonia
- Hepatitis C
- Cohort study
- Staphylococcus aureus
- Clostridium difficile
- Sepsis
- Hepatitis C virus
- Genotype
- Vancomycin
- Tocilizumab
- Cirrhosis
- Emergency department
- Tigecycline
- Skin test
- Position paper
- Immunization
- Clinical trial
- Streptococcus pneumoniae
- Bacteremia
- Infective endocarditis
Journal Specifications
| Overview | |
| Publisher | SPRINGER LONDON LTD |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | GBP 4700 | USD 6850 | EUR 5500 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Article Processing Charges | GBP 4700 | USD 6850 | EUR 5500 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
Planning to publish in Infectious Diseases and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Role of Dolutegravir/Lamivudine in the Management of Pregnant People Living with HIV-1: A Narrative Review.
- 9 Dec 24
- Infectious diseases and therapy
-
Full paper
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.
- 9 Dec 24
- Infectious diseases and therapy
-
Full paper
A Retrospective Claims Data Analysis on the Burden of COVID-19-Related Hospitalization in Adults at High Risk for Severe Disease Progression in Germany.
- 8 Dec 24
- Infectious diseases and therapy
-
Full paper
Acute Infusion-Related Side Effects of AmphotericinB Lipid Complex (ABLC) in Oncohematological Patients: Real-World Data from Brazilian Reference Centers.
- 30 Nov 24
- Infectious diseases and therapy
-
Full paper
Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro Trial.
- 29 Nov 24
- Infectious diseases and therapy
-
Full paper
Real-World Experience of Imipenem-Relebactam Treatment as Salvage Therapy in Difficult-to-Treat Pseudomonas aeruginosa Infections (IMRECOR Study).
- 29 Nov 24
- Infectious diseases and therapy
Scite analysis
Powered by scite_
1k articles received 13.8k citations see all
- 591 Supporting
- 12,661 Mentioning
- 92 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 35 Corrections
- 32 Errata
- 0 Expression of Concern
FAQs
How long has Infectious Diseases and Therapy been actively publishing?
Infectious Diseases and Therapy has been in operation since 2012 till date.
What is the publishing frequency of Infectious Diseases and Therapy ?
Infectious Diseases and Therapy published with a Quarterly frequency.
How many articles did Infectious Diseases and Therapy publish last years ?
In 2023, Infectious Diseases and Therapy published 153 articles.
What is the eISSN & pISSN for Infectious Diseases and Therapy ?
For Infectious Diseases and Therapy,eISSN is 2193-6382 and pISSN is2193-8229.
What is Citescore for Infectious Diseases and Therapy ?
Citescore for Infectious Diseases and Therapy is 6.1.
What is H index for Infectious Diseases and Therapy ?
H index for Infectious Diseases and Therapy is 39.
What is SNIP score for Infectious Diseases and Therapy ?
SNIP score for Infectious Diseases and Therapy is 1.81.
What is the SJR for Infectious Diseases and Therapy ?
SJR for Infectious Diseases and Therapy is Q1.
Who is the publisher of Infectious Diseases and Therapy ?
SPRINGER LONDON LTD is the publisher of Infectious Diseases and Therapy.